290 related articles for article (PubMed ID: 19188865)
1. Serine protease inhibitor 8 is a novel immunohistochemical marker for neuroendocrine tumors of the pancreas.
de Koning PJ; Bovenschen N; Broekhuizen R; Lips CJ; Kummer JA
Pancreas; 2009 May; 38(4):461-7. PubMed ID: 19188865
[TBL] [Abstract][Full Text] [Related]
2. Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours.
Cohen T; Herzog Y; Brodzky A; Greenson JK; Eldar S; Gluzman-Poltorak Z; Neufeld G; Resnick MB
J Pathol; 2002 Sep; 198(1):77-82. PubMed ID: 12210066
[TBL] [Abstract][Full Text] [Related]
3. Secretagogin is a novel marker for neuroendocrine differentiation.
Birkenkamp-Demtröder K; Wagner L; Brandt Sørensen F; Bording Astrup L; Gartner W; Scherübl H; Heine B; Christiansen P; Ørntoft TF
Neuroendocrinology; 2005; 82(2):121-38. PubMed ID: 16449819
[TBL] [Abstract][Full Text] [Related]
4. CD56 expression in ovarian granulosa cell tumors, and its diagnostic utility and pitfalls.
Ohishi Y; Kaku T; Oya M; Kobayashi H; Wake N; Tsuneyoshi M
Gynecol Oncol; 2007 Oct; 107(1):30-8. PubMed ID: 17583777
[TBL] [Abstract][Full Text] [Related]
5. Selective expression of trophoblastic hormones by lung carcinoma: neurendocrine tumors exclusively produce human chorionic gonadotropin alpha-subunit (hCGalpha).
Dirnhofer S; Freund M; Rogatsch H; Krabichler S; Berger P
Hum Pathol; 2000 Aug; 31(8):966-72. PubMed ID: 10987258
[TBL] [Abstract][Full Text] [Related]
6. Chromogranin A plasma concentration and expression in pancreatic islet cell tumors of dogs and cats.
Myers NC; Andrews GA; Chard-Bergstrom C
Am J Vet Res; 1997 Jun; 58(6):615-20. PubMed ID: 9185968
[TBL] [Abstract][Full Text] [Related]
7. The analysis of immunophenotype of gastrin-producing tumors of the pancreas and gastrointestinal tract.
Gurevich L; Kazantseva I; Isakov VA; Korsakova N; Egorov A; Kubishkin V; Bulgakov G
Cancer; 2003 Nov; 98(9):1967-76. PubMed ID: 14584081
[TBL] [Abstract][Full Text] [Related]
8. [Neuroendocrine tumors of pancreas (clinicomorphological, immunohistochemical and electron microscopic study)].
Kazantseva IA; Gurevich LE; Kalinin AP; Borodataia EV; Kuzin NM; Egorov AV; Bronshteĭn MI
Arkh Patol; 1999; 61(6):32-8. PubMed ID: 10664818
[TBL] [Abstract][Full Text] [Related]
9. Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas.
Ryschich E; Huszty G; Knaebel HP; Hartel M; Büchler MW; Schmidt J
Eur J Cancer; 2004 Jun; 40(9):1418-22. PubMed ID: 15177502
[TBL] [Abstract][Full Text] [Related]
10. Histidine decarboxylase expression in pancreatic endocrine cells and related tumors.
Tanimoto A; Matsuki Y; Tomita T; Sasaguri T; Shimajiri S; Sasaguri Y
Pathol Int; 2004 Jun; 54(6):408-12. PubMed ID: 15144399
[TBL] [Abstract][Full Text] [Related]
11. Detection of neuroendocrine feature about salivary adenoid cystic carcinoma.
Sun C; Zhong M; Wang Z; Wang Y
Chin J Dent Res; 1999 Dec; 2(3-4):65-7. PubMed ID: 10863420
[TBL] [Abstract][Full Text] [Related]
12. Synaptophysin and neurofilament proteins as markers for neuroendocrine tumors.
Miettinen M
Arch Pathol Lab Med; 1987 Sep; 111(9):813-8. PubMed ID: 2820344
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical localization of amylin in human pancreas, thyroid, pituitary and their tumors.
Rotondo F; Vidal S; Bell D; Horvath E; Kovacs K; Scheithauer BW; Lloyd RV
Acta Histochem; 2003; 105(4):303-7. PubMed ID: 14656003
[TBL] [Abstract][Full Text] [Related]
14. Chromogranin A-, serotonin-, synaptophysin- and vascular endothelial growth factor-positive endocrine cells and the prognosis of colorectal cancer: an immunohistochemical and ultrastructural study.
Gulubova M; Vlaykova T
J Gastroenterol Hepatol; 2008 Oct; 23(10):1574-85. PubMed ID: 18771509
[TBL] [Abstract][Full Text] [Related]
15. The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors.
Lawrence B; Gustafsson BI; Kidd M; Pavel M; Svejda B; Modlin IM
Endocrinol Metab Clin North Am; 2011 Mar; 40(1):111-34, viii. PubMed ID: 21349414
[TBL] [Abstract][Full Text] [Related]
16. Multiple glucagon-producing pancreatic neuroendocrine tumors in a horse (Equus caballus).
Herbach N; Nagel L; Zwick T; Hermanns W
Vet Pathol; 2014 May; 51(3):607-11. PubMed ID: 23774746
[TBL] [Abstract][Full Text] [Related]
17. Identification of molecular markers specific for pancreatic neuroendocrine tumors by genetic profiling of core biopsies.
Bloomston M; Durkin A; Yang I; Rojiani M; Rosemurgy AS; Enkmann S; Yeatman TJ; Zervos EE
Ann Surg Oncol; 2004 Apr; 11(4):413-9. PubMed ID: 15070602
[TBL] [Abstract][Full Text] [Related]
18. Expression of neuroendocrine markers: a signature of human undifferentiated carcinoma of the colon and rectum.
Grabowski P; Schönfelder J; Ahnert-Hilger G; Foss HD; Heine B; Schindler I; Stein H; Berger G; Zeitz M; Scherübl H
Virchows Arch; 2002 Sep; 441(3):256-63. PubMed ID: 12242522
[TBL] [Abstract][Full Text] [Related]
19. [Pathogenesis of endocrine tumors of the pancreas].
Kimura W
Nihon Geka Gakkai Zasshi; 2008 May; 109(3):133-42. PubMed ID: 18536316
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine markers expression in pancreatic serous cystadenoma.
Kanehira K; Khoury T
Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):141-6. PubMed ID: 21030861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]